Firms Should Look To Local CROs For Clinical Trials in Asia
This article was originally published in PharmAsia News
Executive Summary
When conducting clinical trials in Asia, it may be more advantageous for firms to do business with locally-owned contract research organizations rather than a global CRO with a local office, an Asia medical consultant suggests